DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Lyka Labs Q1 Results: Revenue Jumps 46% to ₹42 Cr as Q1 Profit Surges 159%

Trade Brains 2 hrs ago·10 Aug 2026, 7:45 am

Synopsis: Lyka Labs has started FY27 on a markedly stronger footing, with the pharmaceutical company returning to profit and delivering a sharp improvement in revenue during the June quarter. But alongside the earnings recovery, the company has taken a significant portfolio decision by approving the sale of its entire stake in a subsidiary that contributed […] The post Lyka Labs Q1 Results: Revenue Jumps 46% to ₹42 Cr as Q1 Profit Surges 159% appeared first on Trade Brains.